SAN DIEGO, Nov. 6, 2017 /CNW/ -- ResMed (NYSE:
RMD, ASX: RMD) today announced that AirMini, the world's smallest
PAP (positive airway pressure) device, is now connected to AirView,
the world's largest remote patient monitoring platform.
Experience the interactive Multichannel News Release here:
https://www.multivu.com/players/English/74629528-resmed-airmini-now-airview-enabled/
The connectivity between AirMini and AirView enables clinicians
to see patients' nightly data, verify adherence, and spot therapy
issues – giving them a great opportunity to educate and engage
patients to reach the best possible health outcomes.
Remote monitoring is the latest feature on AirMini, ResMed's
0.66-pound PAP device that also has self-monitoring tools, letting
patients see their own nightly data with an app on their iOS or
Android phones.
Monitoring is a key factor in keeping patients healthy through
regular therapy use; a recent study showed that more than 87
percent of patients were adherent when remote and self-monitoring
tools were used.
"AirMini and AirView are the perfect pair for traveling with
CPAP and APAP therapy," said ResMed CEO Mick Farrell. "ResMed has combined self- and
remote monitoring and waterless humidification to put a
world-class, world-traveling therapy experience literally in the
palm of your hand."
Once patients download or update the latest "AirMini by ResMed
1.2" app, and opt in to upload data to the cloud, home medical
equipment (HME) providers can view the same reports, charts, notes
and therapy thresholds in AirView like they can for ResMed's
bedside Air10 devices, helping them monitor more patients in less
time. HMEs can register their patients' AirMini devices through
AirView, Brightree or U-Sleep patient management platforms just as
they would a ResMed Air10 bedside device.
AirMini is available in 15 countries across North America, Europe and Asia-Pacific, with more countries to
follow.
About ResMed
ResMed (NYSE: RMD, ASX: RMD) changes
lives with award-winning medical devices and cloud-based software
applications that better diagnose, treat and manage sleep apnea,
chronic obstructive pulmonary disease (COPD) and other chronic
diseases. ResMed is a global leader in connected care, with more
than 4 million patients remotely monitored every day. Our
6,000-strong team is committed to creating the world's best
tech-driven medical device company – improving quality of life,
reducing the impact of chronic disease, and saving healthcare costs
in more than 120 countries. ResMed.com | Facebook | Twitter |
LinkedIn
For
media:
|
For
investors:
|
Jayme
Rubenstein
|
Agnes Lee
|
+1
858-836-6798
|
+1
858-836-5971
|
news@resmed.com
|
investorrelations@resmed.com
|
View original
content:http://www.prnewswire.com/news-releases/resmed-adds-remote-patient-monitoring-to-airmini-worlds-smallest-cpap-300549549.html
SOURCE ResMed Inc.